Clinical Scorecard: Recurrent Gonococcemia Uncovers X-Linked Properdin Deficiency: A Unique Case Study

At a Glance

Key Highlights

• Properdin deficiency, known for meningococcal disease risk, is newly reported as a risk factor for recurrent DGI.
• Recurrent DGI should prompt investigation of alternative complement pathway deficiencies including properdin deficiency.
• Vaccination against meningococcal, pneumococcal, and Haemophilus influenzae type b infections is recommended in properdin deficiency.

Guideline-Based Recommendations

Diagnosis

• Consider DGI diagnosis in patients with fever, papulopustular purpuric rash, and tenosynovitis or arthritis.
• Perform blood cultures and PCR testing for Neisseria gonorrhoeae and other STIs.
• Investigate complement system function including C3, C4, CH50, and specifically alternative pathway activity (AP50 assay).
• Measure properdin antigen levels and confirm diagnosis with genetic testing for properdin gene mutations.

Management

• Treat DGI with appropriate cephalosporin antibiotics promptly.
• Administer vaccinations per guidelines for properdin deficiency: meningococcal B, ACYW tetravalent meningococcal, pneumococcal, and Haemophilus influenzae type b vaccines.
• Recommend HIV preexposure prophylaxis if indicated by exposure risk.
• Advise genetic counseling and family screening due to X-linked inheritance.

Monitoring & Follow-up

• Monitor clinical response to antibiotic therapy during DGI episodes.
• Follow up on vaccination status and immune function.
• Surveillance for recurrent infections and other gram-negative diplococci infections.

Risks

• Increased risk of invasive infections by gram-negative diplococci including Neisseria gonorrhoeae and Neisseria meningitidis.
• Potential underdiagnosis of properdin deficiency in patients with recurrent DGI.
• Risk of transmission of X-linked mutation to male relatives.

Patient & Prescribing Data

Adult male with recurrent disseminated gonococcal infections and confirmed X-linked properdin deficiency

Cephalosporin antibiotics effectively treat acute DGI episodes; vaccination and prophylaxis are critical for prevention of invasive infections.

Clinical Best Practices

• Maintain high suspicion for complement deficiencies in recurrent DGI cases.
• Perform comprehensive STI screening in patients presenting with DGI.
• Implement alternative complement pathway testing including AP50 and properdin antigen assays early in recurrent or severe cases.
• Provide targeted vaccinations according to immunodeficiency guidelines.
• Encourage genetic counseling and family member evaluation for X-linked properdin deficiency.

References

• Increasing rates of gonorrhea and cephalosporin resistance
• French vaccination guidelines for properdin deficiency
• Complement system role in defense against gram-negative diplococci
• Properdin gene mutations and clinical implications
• HIV preexposure prophylaxis recommendations
• Clinical manifestations of disseminated gonococcal infection